Results

Cadrenal Therapeutics Inc.

11/22/2024 | Press release | Archived content

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 22, 2024 5:00 P.M.
Form: S-3
CIK: 0001937993
Company Name: Cadrenal Therapeutics, Inc.
File Number: 333-283226